Results 151 to 160 of about 5,835 (207)
Some of the next articles are maybe not open access.
Nonprescription Drugs: An Overview
International Journal of Health Services, 1974This article discusses a widely used class of medicinal agents—nonprescription drugs. The pertinent legislation affecting nonprescription drugs is reviewed historically, followed by a discussion of recent federal regulatory actions, especially those of the review panels convened by the United States Food and Drug Administration. The problems associated
exaly +3 more sources
Nonprescription drugs and hypertension
Postgraduate Medicine, 1991Hypertensive patients should be aware of the possible effects of nonprescription medications on blood pressure control. For absolute safety, no adrenergic agents should be used. Nasal phenylephrine hydrochloride is probably the safest of these agents, and pseudoephedrine hydrochloride may also be safe.
J G Bradley
exaly +3 more sources
Nonprescription Drugs in Germany
Drug Information Journal, 1994Nonprescription medicinal products, which include over-the-counter and some homeopathic and herbal medicines, comprise a large part of the pharmaceutical market in Germany, accounting for 35% of all sales in 1992. This paper reviews definitions, markets, the legal framework, and future prospects.
exaly +2 more sources
International Journal of Environmental Research and Public Health, 2022 Breastfeeding women may experience various health issues that require medication. This survey aimed to gain insights into the use of nonprescription and prescription drugs by breastfeeding women in Japan.
Yukiko Fujii +2 more
exaly +2 more sources
Pharmacoepidemiology of nonprescription drugs [PDF]
, 1998 Background: In recent years there have been trends towards increased use of. nonprescription medicines and a greater number of products being switched from prescription-only to nonprescription status. When used properly nonprescription products can be safe and effective treatments, however it is not clear that patients do actually use these products in
Williams, Kylie Anne
openaire +2 more sources
Current Cardiology Reports, 2023 Purpose of review: Statins inhibit the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase in the liver and reduce atherosclerotic cardiovascular disease (ASCVD) risk by enhancing low-density lipoprotein (LDL) clearance from the circulation.
Anurag Mehta, Dave L Dixon, Anum Saeed
exaly +2 more sources
Clinical Pharmacology and Therapeutics, 2011 Nonprescription drugs pose unique challenges to regulators. The fact that the barriers to access are lower for nonprescription drugs as compared with prescription drugs may permit additional consumers to obtain effective drugs.
O Renn
exaly +2 more sources
A Decision‐Analysis Tool for Benefit–Risk Assessment of Nonprescription Drugs
Journal of Clinical Pharmacology, 2013 A decision analysis tool is proposed for regulatory assessment of nonprescription drugs. The tool is based on evaluation of each of the drug's potential benefit and risk attributes identified using a value-tree framework. The decision tool is designed as
Ragnar Löfstedt, Ortwin Renn
exaly +2 more sources